Shah Harsh, Bradford Carol, Sayar Hamid
Indiana University Simon Cancer Center, Indianapolis, IN, USA.
Eli Lilly and Company, Indianapolis, IN, USA.
Case Rep Hematol. 2015;2015:826894. doi: 10.1155/2015/826894. Epub 2015 Jul 12.
We report a case of acute promyelocytic leukemia (APL) presenting with severely fibrotic marrow. There are four other reports of similar cases in the literature. Our patient was treated with All-Transretinoic Acid- (ATRA-) containing induction chemotherapy, followed by consolidation and maintenance therapy. He achieved a complete morphologic remission with adequate count recovery in a timely fashion, and later a molecular remission was documented. The patient remains in molecular remission and demonstrates normal blood counts now more than 4 years after induction. Since the morphological appearance may not be typical and the bone marrow may not yield an aspirate for cytogenetic analysis, awareness of such entity is important to make a correct diagnosis of this potentially curable disease.
我们报告一例急性早幼粒细胞白血病(APL)伴有严重骨髓纤维化。文献中另有4例类似病例的报道。我们的患者接受了含全反式维甲酸(ATRA)的诱导化疗,随后进行巩固和维持治疗。他及时实现了完全形态学缓解且血细胞计数充分恢复,随后记录到分子学缓解。诱导治疗4年多后,患者仍处于分子学缓解状态,血细胞计数正常。由于形态学表现可能不典型且骨髓可能无法获取用于细胞遗传学分析的抽吸物,认识到这类情况对于正确诊断这种潜在可治愈的疾病很重要。